<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04680481</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00004009</org_study_id>
    <secondary_id>RF1MH124909</secondary_id>
    <nct_id>NCT04680481</nct_id>
  </id_info>
  <brief_title>Non-Invasive Brain Stimulation to Control Large-Scale Brain Networks</brief_title>
  <official_title>Traveling Wave Transcranial Alternating Current Stimulation for the Control of Large-Scale Brain Networks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will assess the feasibility of traveling wave transcranial alternating current&#xD;
      stimulation (tACS) to modify working memory performance and large-scale brain connectivity in&#xD;
      surgical epilepsy patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Electrophysiological outcomes</measure>
    <time_frame>Immediate effect during stimulation</time_frame>
    <description>Changes in spectral power and coherence of the local field potentials during transcranial electric stimulation relative to no stimulation periods.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Working memory outcomes</measure>
    <time_frame>Immediate effect during stimulation</time_frame>
    <description>Changes in working memory performance as measured with the N-back task (quantified with d-prime) during stimulation.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Working Memory</condition>
  <arm_group>
    <arm_group_label>Stimulation Theta Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will experience traveling wave transcranial alternating current stimulation over the fronto-parietal regions at 4 Hz (theta condition).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stimulation Beta Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will experience traveling wave transcranial alternating current stimulation over the fronto-parietal regions at 23 Hz (beta condition).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial alternating current stimulation</intervention_name>
    <description>Traveling wave transcranial alternating current stimulation will be applied at 4 Hz and 23 Hz over frontal and parietal brain areas in a randomized counterbalanced order.</description>
    <arm_group_label>Stimulation Beta Group</arm_group_label>
    <arm_group_label>Stimulation Theta Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. the patient can consent for themselves;&#xD;
&#xD;
          2. the patient has or is scheduled for surgically implanted electrodes for the purposes&#xD;
             of phase II epilepsy surgical evaluation;&#xD;
&#xD;
          3. age 18+ years old;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. diminished capacity to consent;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Opitz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander Opitz, PhD</last_name>
    <phone>612-624-1094</phone>
    <email>aopitz@umn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ivan Alekseichuk, PhD</last_name>
    <phone>612-624-1118</phone>
    <email>ialeksei@umn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivan Alekseichuk, PhD</last_name>
      <phone>612-626-1118</phone>
      <email>ialeksei@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Alexander Opitz, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ivan Alekseichuk, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 14, 2020</study_first_submitted>
  <study_first_submitted_qc>December 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2020</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified data will be shared following the IRB guidelines and Data Sharing Policy for the National Institute of Mental Health (NOT-MH-19-033).</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

